Evaluation of a Gatekeeper Training for Pharmacists

Suicide Clinical Trial

Official title:

Evaluation of a Gatekeeper Training for Pharmacists

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05991635
• Other study ID #: ONZ-2022-0598
• Status: Completed
• Phase: N/A
• Start date: April 12, 2023
• Est. completion date: January 11, 2024

Study information

• Verified date: February 2024
• Source: University Ghent
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to investigate to what extent a gatekeeper training (e-learning) for pharmacists and PTA is effective in changing the attitudes, knowledge, and self-efficacy. Moreover, it aims to examine how they evaluate the training and whether they were able to apply the learned skills in practice.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 201
• Est. completion date: January 11, 2024
• Est. primary completion date: January 11, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• = 18 years old

• Have access to internet

• Speak Dutch

• Working as a (public) pharmacist or pharmaceutical technical assistant (FTA)

Exclusion Criteria:

• Hospital pharmacists or industrial pharmacists are not included in this study and thus constitute an exclusion criterion.

Related Conditions & MeSH terms

• Suicide

Intervention

Behavioral:
• Gatekeeper training (e-learning)
The gatekeeper training consists of an interactive e-learning (min. 1h, max. 3h) which includes theoretical knowledge, tips, exercises and relevant examples and cases. The main topics included in the e-learning are: Background information on suicide in Flanders (rates) Definitions and theoretical background (suicidal process, integrative explanatory model of suicide) Debunking existing myths about suicide The role of the pharmacist in suicide prevention Signal Recognition Talking about suicide and suicidal thoughts (start the conversation) How and to whom to refer as pharmacist or FTA Medication management and medication in the context of suicide Rights and obligations of a pharmacist/PTA in the context of suicide prevention Self-care

Locations

Country	Name	City	State
Belgium	Flemish Centre of Expertise in Suicide Prevention, Ghent University	Ghent

Sponsors (1)

Lead Sponsor	Collaborator
University Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Socio-demographic characteristics	Age, Gender, Years of work experience	Baseline
Other	Previous experience with suicide (prevention)	At baseline: motivation to participate (9 options), previous trainings (yes/no, specify if yes) At baseline and post-test: experience with suicidal patients (contact and confidence; 5 point Likert scale), knowing what to do or who to refer to (5-point Likert scale), knowing where to find information (5-point Likert scale), which actions previously taken in case of suicidal patient (list of 12), to who do you refer (5 options)	Baseline and post-test (after a week of access to e-learning)
Other	Follow-up	Questions concerning: application of acquired skills and knowledge; actions undertaken in context of suicide prevention (12 options); experienced barriers to application of acquired skills and knowledge; need of extra support	Follow-up (three months after baseline)
Primary	Changes in attitudes: Attitudes Towards Suicide Scale (ATTS)	The ATTS is a 37-item to be scored on a 5-point Likert scale (1= disagree completely to 5 = agree completely) to measure participants' attitudes towards suicide.	Change from Baseline (before intervention) to post-test (after a week of access to e-learning)
Secondary	Changes in self-efficacy: Measurement of Perceived Self-efficacy	The Measurement of Perceived Self-efficacy is a 10-item self-report questionnaire to be scored on a 4-point Likert scale (1= Completely false to 4 = completely true)	Change from Baseline (before intervention) to post-test (after a week of access to e-learning)
Secondary	Changes in perceptions/myths	Self-developped questionnaire: 4 statements to be rated as true or false; 2 question about how participant would feel if a patient said they have suicidal thouhgts	Change from Baseline (before intervention) to post-test (after a week of access to e-learning)
Secondary	Gatekeeper training evaluation	8 evaluative statements about the e-learning to be rated on a 5-point Likert scale (Totally disagree, disagree, neutral, agree, totally disagree).; Question to rate the e-learning on a scale of 1 (not good at all) to 10 (excellent) Additionally three open questions where participants can give feedback about what they liked/did not like/ general comments.	Post-test (after a week of access to e-learning)